Answer
It is licensed for defined adults with early-stage, hormone receptor-positive, HER2-overexpressed or amplified breast cancer following adjuvant trastuzumab-based therapy.
Sources for this answer
- Nerlynx 40 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.